Meptin Tablet (procaterol) / Otsuka - LARVOL DELTA

Effects of oral doxofylline and procaterol on chronic obstructive pulmonary disease: A randomized crossover study (ERS 2025) - "Aims and objectives: This study aimed to evaluate the effects of oral doxofylline and oral procaterol on lung functions and clinical symptoms in COPD patients. Doxofylline improved pulmonary function in COPD patients but did not provide superior functional performance compared to procaterol. Neurological adverse events were more frequently associated with doxofylline."

Clinical • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study. (PubMed, Med Sci (Basel)) - "This study aimed to evaluate the effects of oral doxofylline and oral procaterol on lung function and clinical symptoms in COPD patients. Neurological adverse events were more frequently associated with doxofylline. Doxofylline may serve as an adjunctive therapy to enhance pulmonary function in COPD patients, but caution is advised due to its potential side effects."

Clinical • Journal • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

Effects of Oral Procaterol for Postinfectious Cough in Adults: Single-Centre, Randomized Double-Blind, Placebo-Controlled Trial. (PubMed, Korean J Fam Med) - P=N/A | "No differences between groups were found in the mean changes of spirometry or IOS parameters after 4 weeks. Our study shows that procaterol is not effective in the treatment of PIC, in terms of improvement of cough-specific QoL or peripheral-airway function."

Clinical • Journal • Asthma • Immunology • Infectious Disease • Respiratory Diseases